Benien E. van Aken

1.2k total citations
15 papers, 1.0k citations indexed

About

Benien E. van Aken is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Benien E. van Aken has authored 15 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Hematology and 4 papers in Immunology. Recurrent topics in Benien E. van Aken's work include Blood Coagulation and Thrombosis Mechanisms (4 papers), Folate and B Vitamins Research (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). Benien E. van Aken is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (4 papers), Folate and B Vitamins Research (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). Benien E. van Aken collaborates with scholars based in Netherlands and United States. Benien E. van Aken's co-authors include Pieter H. Reitsma, Tanja A.E. van Achterberg, Carlie J.M. de Vries, Rolf G. Boot, G. Herma Renkema, Michael J. Jacobs, Johannes M. F. G. Aerts, Hein Fennema, Nick R. Bijsterveld and Marcel Levi and has published in prestigious journals such as Circulation, Circulation Research and Gut.

In The Last Decade

Benien E. van Aken

15 papers receiving 982 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benien E. van Aken Netherlands 12 373 279 253 232 188 15 1.0k
Kristina L. Modjeski United States 7 156 0.4× 73 0.3× 128 0.5× 79 0.3× 259 1.4× 9 737
Julia Barbara Kral Austria 12 206 0.6× 53 0.2× 119 0.5× 122 0.5× 195 1.0× 18 868
Matthieu Rousseau Canada 11 427 1.1× 49 0.2× 64 0.3× 100 0.4× 203 1.1× 15 863
S R Poort Netherlands 18 161 0.4× 534 1.9× 280 1.1× 139 0.6× 1.2k 6.3× 35 1.4k
Madhu S. Bajaj United States 11 140 0.4× 99 0.4× 88 0.3× 68 0.3× 413 2.2× 20 730
Turid M. Pedersen Norway 14 213 0.6× 29 0.1× 138 0.5× 78 0.3× 146 0.8× 24 678
Lisa J. Toltl Canada 14 239 0.6× 49 0.2× 125 0.5× 186 0.8× 345 1.8× 17 1.1k
Hideo Wada Japan 13 106 0.3× 105 0.4× 57 0.2× 94 0.4× 251 1.3× 32 698
Patricia Molina Spain 15 211 0.6× 158 0.6× 212 0.8× 54 0.2× 157 0.8× 31 776
P. Hartl Austria 15 187 0.5× 47 0.2× 237 0.9× 166 0.7× 38 0.2× 47 741

Countries citing papers authored by Benien E. van Aken

Since Specialization
Citations

This map shows the geographic impact of Benien E. van Aken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benien E. van Aken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benien E. van Aken more than expected).

Fields of papers citing papers by Benien E. van Aken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benien E. van Aken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benien E. van Aken. The network helps show where Benien E. van Aken may publish in the future.

Co-authorship network of co-authors of Benien E. van Aken

This figure shows the co-authorship network connecting the top 25 collaborators of Benien E. van Aken. A scholar is included among the top collaborators of Benien E. van Aken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benien E. van Aken. Benien E. van Aken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Aken, Benien E. van, et al.. (2007). The pharmacokinetics and effects of a long‐acting preparation of superoxide dismutase (PC‐SOD) in man. British Journal of Clinical Pharmacology. 65(1). 22–29. 22 indexed citations
2.
Peeters, A. C. T. M., Benien E. van Aken, Henk J. Blom, Pieter H. Reitsma, & Martin den Heijer. (2007). The effect of homocysteine reduction by B-vitamin supplementation on inflammatory markers. Clinical Chemistry and Laboratory Medicine (CCLM). 45(1). 54–8. 19 indexed citations
3.
Rittersma, Saskia Z.H., Johanna A. Kremer Hovinga, Karel T. Koch, et al.. (2005). Relationship between In Vitro Lipopolysaccharide-Induced Cytokine Response in Whole Blood, Angiographic In-Stent Restenosis, and Toll-Like Receptor 4 Gene Polymorphisms. Clinical Chemistry. 51(3). 516–521. 11 indexed citations
4.
Bijsterveld, Nick R., Roel Vink, Benien E. van Aken, et al.. (2004). Recombinant factor VIIa reverses the anticoagulant effect of the long‐acting pentasaccharide idraparinux in healthy volunteers. British Journal of Haematology. 124(5). 653–658. 82 indexed citations
5.
Sommeijer, Dirkje W., Casper G. Schalkwijk, Chris M. van der Loos, et al.. (2004). More Fibrosis and Thrombotic Complications but Similar Expression Patterns of Markers for Coagulation and Inflammation in Symptomatic Plaques from DM2 Patients. Journal of Histochemistry & Cytochemistry. 52(9). 1141–1149. 13 indexed citations
6.
Aken, Benien E. van, Pieter H. Reitsma, & Frits R. Rosendaal. (2002). Interleukin 8 and venous thrombosis: evidence 
for a role of inflammation in thrombosis. British Journal of Haematology. 116(1). 173–177. 102 indexed citations
7.
Maraha, B., Marc Peeters, Benien E. van Aken, & Martin den Heijer. (2002). Chlamydia pneumoniae, systemic inflammation and the risk of venous thrombosis. Diagnostic Microbiology and Infectious Disease. 42(3). 153–157. 5 indexed citations
8.
Bijsterveld, Nick R., Arno H. Moons, S. Matthijs Boekholdt, et al.. (2002). Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers. Circulation. 106(20). 2550–2554. 225 indexed citations
9.
Aken, Benien E. van, J. Jansen, Sander J. H. van Deventer, & Pieter H. Reitsma. (2000). Elevated levels of homocysteine increase IL-6 production in monocytic Mono Mac 6 cells. Blood Coagulation & Fibrinolysis. 11(2). 159–164. 40 indexed citations
10.
Aken, Benien E. van, et al.. (2000). Elevated levels of homocysteine increase IL-6 production in monocytic Mono Mac 6 cells. Blood Coagulation & Fibrinolysis. 11(2). 159–164. 28 indexed citations
11.
Engelse, Marten A., Tanja A.E. van Achterberg, Benien E. van Aken, et al.. (1999). Human Activin-A Is Expressed in the Atherosclerotic Lesion and Promotes the Contractile Phenotype of Smooth Muscle Cells. Circulation Research. 85(10). 931–939. 65 indexed citations
12.
Aken, Benien E. van. (1999). Inflammatory markers, vascular disease and homocysteine. UvA-DARE (University of Amsterdam). 2 indexed citations
13.
Boot, Rolf G., Tanja A.E. van Achterberg, Benien E. van Aken, et al.. (1999). Strong Induction of Members of the Chitinase Family of Proteins in Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 19(3). 687–694. 294 indexed citations
14.
Stokkers, Pieter, et al.. (1998). Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut. 43(1). 33–39. 66 indexed citations
15.
Aken, Benien E. van, et al.. (1997). Localization of vitronectin in the normal and atherosclerotic human vessel wall. Histochemistry and Cell Biology. 107(4). 313–320. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026